Strategy and Status of Neoadjuvant Therapy for HER2-positive Breast Cancer

Strategy and Status of Neoadjuvant Therapy for HER2-positive Breast Cancer

Neoadjuvant therapy is a preoperative systemic treatment for patients with breast cancer. This therapy has greatly improved the clinical outcomes of human epidermal growth factor receptor 2 (HER2)-positive breast cancer, which is associated with poor prognosis. Currently, dual anti-HER2 antibodies,...

Full description

Bibliographic Details
Main Authors: LIU Yunjiang, YANG Chao
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2024-01-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
her2-positive breast cancer
neoadjuvant therapy
pcr
trastuzumab
pertuzumab
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2024.23.0942

Similar Items

Similar Items